Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: Prevalence, risk factors of colonization and outcome

Rheumatology

Volumn 50, Issue 3, 2011, Pages 569-577

  Mekinian, Arsene ^a   Durand Joly, Isabelle ^b   Hatron, Pierre Yves ^a   Moranne, Olivier ^c   Denis, Guillaume ^a   Dei Cas, Eduardo ^b   Morell Dubois, Sandrine ^a   Lambert, Marc ^a   Launay, David ^a   Delhaes, Laurence ^b   Hachulla, Eric ^a   Queyrel, Viviane ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Colonization; Pneumocystis jirovecii; Polymerase chain reaction; Systemic autoimmune diseases

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; FUNGAL DETECTION; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYOSITIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCREENING; SPUTUM ANALYSIS; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS;

AGED; AUTOIMMUNE DISEASES; FEMALE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SPUTUM;

EID: 79952023690     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq314     Document Type: Article

References (42)

1. Monnet X, Vidal-Petiot E, Osman D et al. Critical care management and outcome of severe pneumocystis pneumonia in patients with and without HIV infection. Crit Care Med 2008;12:1-10.
2. Dei-Cas E. Pneumocystis infections: the iceberg? Med Mycol 2000;38:23-32.
3. Arend SM, Kroon FP, van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Int Med 1995;155: 2436-41.
4. Khellaf M, Godeau B. Pneumocystis pneumonia among patients with systemic diseases. Presse Med 2009;38: 251-9.
5. Sowden E, Carmichael AJ. Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis 2004;16:42.
6. Morris A, Wei K, Afshar K et al. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 2008;197:10-7.
7. Durand-Joly I, Chabé M, Camus D et al. Molecular diagnosis of pneumocystis pneumonia. FEMS Immunol Med Microbiol 2005;45:405-10.
8. Mekinian A, Queyrel V, Durand-Joly I et al. Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or colonisation? Rev Med Int 2009 (in press).
9. Wakefield AE. DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol 1996;34: 1754-9.
10. Durand-Joly I, Aliouat EM, Recourt C et al. Human-derived Pneumocystis is not infectious to SCID mice. J Clin Microbiol 2002;40:1862-5.
11. Mori S, Cho I, Ichiyasu H, Sugimoto M. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol 2007;8:1-9.
12. Durand-Joly X, Soula F, Chabé M et al. Long-term colonization with Pneumocystis jirovecii in hospital staffs: a challenge to prevent nosocomial pneumocystosis. J Eukaryot Microbiol 2003;4:614-5.
13. Medrano F, Montes-Cano M, Conde M et al. Pneumocystis jirovecii in general population. Emerg Infect Dis 2005;11:245-50.
14. Morris A, Kingsley LA, Lebedeva IP et al. Prevalence and clinical predictors of pneumocystis colonization among HIV-infected men. AIDS 2004;18:793-8.
15. Ward M, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue disease. Arthritis Rheum 1999;42:780-9.
16. Molina JF, Drenkard C, Molina J et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine 1996;75:124-30.
17. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine 2006;85: 147-56.
18. Assassi S, Del Junco D, Sutter K et al. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009;61:1403-11.
19. Dei-Cas E, Brun-Pascaud M, Bille-Hansen V et al. Animal models of pneumocystosis. FEMS Immunol Med Microbiol 1998;22:163-8.
20. Maskell NA, Waine DJ, Lindley A. Asymptomatic carriage of Pneumocystis jirovecii in subjects undergoing bronchoscopy: a prospective study. Thorax 2003;58: 594-7.
21. Helweg-Larsen J, Jensen JS, Dohn B et al. Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia-a case control study. BMC Infect Dis 2002;2:28.
22. Varela JM, Respaldiza N, Sanchez B et al. Lymphocyte response in subjects with chronic pulmonary disease colonized by Pneumocystis jirovecii. J Eukaryot Microbiol 2003;50:672-3.
23. Leigh TR, Kangro HO, Gazzard BG et al. DNA amplification by the polymerase chain reaction to detect subclinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med 1993; 87:525-9.
24. Huang L, Crothers K, Morris A et al. Pneumocystis colonization in HIV-infected patients. J Eukaryot Microbiol 2003;50:616-7.
25. Wakefield AE, Lindley AR, Ambrose HE et al. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J Infect Dis 2003;187:901-8.
26. + T cell counts. Clin Infect Dis 1999;29: 1331-2.
27. Suryaprasad A, Stone J. When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases. Arthritis Rheum 2008;59:1034-9.
28. Calderón EJ, Regordan C, Medrano FJ et al. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet 1996;347:977.
29. Morris A, Sciurba FC, Lebedeva IP et al. Association of chronic obstructive disease severity and pneumocystis colonization. Am J Respir Crit Care Med 2004;170: 408-13.
30. Vidal S, Martin J. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 2006;12:231-5.
31. Sato T, Inokuma S, Maezawa R et al. Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol 2005;15: 191-7.
32. Saito K, Nakayamada S, Nakano K et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: revaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology 2004;43:479-85.
33. Elvin K, Olsson M, Lidman C et al. Detection of asymptomatic Pneumocystis carinii infection by PCR: predictive for subsequent pneumonia. AIDS 1996;10: 1297-8.
34. Mori S, Cho I, Sugimoto M. A follow-up of asymptomatic carriers of Pneumocystis jirovecii during immunosuppressive therapy of rheumatoid arthritis. J Rheum 2009;36:8.
35. Chabé M, Dei-Cas E, Creusy C et al. Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis 2004;23:89-97.
36. Gigliotti F, Harmsen AG, Wright TW. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun 2003;71: 3852-6.
37. Ri Rivero L, de la Horra C, Montes-Cano MA et al. Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg Infect Dis 2008;14:1116-8.
38. Vargas S, Ponce C, Gigliotti F et al. Transmission of pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol 2000;38:1536-8.
39. Miller RF, Ambrose HE, Wakefield AE. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J Clin Microbiol 2001;39:3877-82.
40. Calderon EJ, Rivero L, Respaldiza N. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clin Infect Dis 2007;45:17-9.
41. Kaur N, Mahl T. Pneumocystis jirovecii (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007;52:1481-4.
42. Teichmann LL, Woenckhaus M, Vogel C et al. Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology 2008;47: 1256-7.